Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 4
2010 1
2011 1
2012 1
2015 1
2016 2
2017 2
2018 5
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D. Van Cutsem E, et al. Among authors: aranda aguilar e. Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5. Ann Oncol. 2016. PMID: 27380959 Free article.
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Shitara K, Özgüroğlu M, Bang YJ, Di Bartolomeo M, Mandalà M, Ryu MH, Fornaro L, Olesiński T, Caglevic C, Chung HC, Muro K, Goekkurt E, Mansoor W, McDermott RS, Shacham-Shmueli E, Chen X, Mayo C, Kang SP, Ohtsu A, Fuchs CS; KEYNOTE-061 investigators. Shitara K, et al. Lancet. 2018 Jul 14;392(10142):123-133. doi: 10.1016/S0140-6736(18)31257-1. Epub 2018 Jun 4. Lancet. 2018. PMID: 29880231 Clinical Trial.
Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept.
González Astorga B, Salvà Ballabrera F, Aranda Aguilar E, Élez Fernández E, García-Alfonso P, González Flores E, Vera García R, Fernández Montes A, López Muñoz AM, Salud Salvia A. González Astorga B, et al. Among authors: aranda aguilar e. Clin Transl Oncol. 2021 Aug;23(8):1520-1528. doi: 10.1007/s12094-021-02568-y. Epub 2021 Feb 25. Clin Transl Oncol. 2021. PMID: 33630242 Free PMC article. Review.
Clinical practice guidelines on antiemetics in oncology.
Aranda Aguilar E, Constenla Figueiras M, Cortes-Funes H, Diaz-Rubio García E, Gascon Vilaplana P, Guillém V, Martin-Algarra S. Aranda Aguilar E, et al. Expert Rev Anticancer Ther. 2005 Dec;5(6):963-72. doi: 10.1586/14737140.5.6.963. Expert Rev Anticancer Ther. 2005. PMID: 16336087 Review.
A panel discussion of controversies and challenges in the adjuvant treatment of colon cancer.
Díaz-Rubio García E, Abad Esteve A, Antón Torres A, Aranda Aguilar E, Benavides Orgaz M, Carrato Mena A, Cervantes Ruipérez A, Feliu Batle J, García Alfonso P, García Foncillas J, Grávalos Castro C, Navarro García M, Rivera Herrero F, Tabernero Caturla JM. Díaz-Rubio García E, et al. Among authors: aranda aguilar e. Clin Transl Oncol. 2005 Jan-Feb;7(1):3-11. doi: 10.1007/BF02710019. Clin Transl Oncol. 2005. PMID: 15890149 Review.
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP).
Camps Herrero C, Reina Zoilo JJ, Monge Martín D, Caballero Martínez F, Guillem Porta V, Aranda Aguilar E, Carrato Mena A, Díaz-Rubio García E, García-Foncillas López J, Feijóo Saus M, López López R. Camps Herrero C, et al. Among authors: aranda aguilar e. Clin Transl Oncol. 2019 Mar;21(3):380-390. doi: 10.1007/s12094-018-1925-1. Epub 2018 Aug 9. Clin Transl Oncol. 2019. PMID: 30094793 Free article.
Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil.
Morales Chamorro R, Serrano Blanch R, Méndez Vidal MJ, Gómez España MA, Rubio Pérez MJ, de la Haba Rodríguez JR, Aranda Aguilar E. Morales Chamorro R, et al. Among authors: aranda aguilar e. Clin Transl Oncol. 2005 Jul;7(6):258-61. doi: 10.1007/BF02710173. Clin Transl Oncol. 2005. PMID: 16131450
[Treatment of choroidal melanoma. Study of 13 cases].
González-Santiago S, Expósito Ordóñez A, Barneto Aranda IC, Aranda Aguilar E. González-Santiago S, et al. Among authors: aranda aguilar e. Med Clin (Barc). 2005 Mar 26;124(11):438-9. doi: 10.1157/13072859. Med Clin (Barc). 2005. PMID: 15799857 Spanish. No abstract available.
KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.
Morales-Estevez C, De la Haba-Rodriguez J, Manzanares-Martin B, Porras-Quintela I, Rodriguez-Ariza A, Moreno-Vega A, Ortiz-Morales MJ, Gomez-España MA, Cano-Osuna MT, Lopez-Gonzalez J, Chia-Delgado B, Gonzalez-Fernandez R, Aranda-Aguilar E. Morales-Estevez C, et al. Among authors: aranda aguilar e. Front Immunol. 2016 Dec 5;7:561. doi: 10.3389/fimmu.2016.00561. eCollection 2016. Front Immunol. 2016. PMID: 27994592 Free PMC article.
Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study.
López López R, Camps Herrero C, Khosravi-Shahi P, Guillem Porta V, Carrato Mena A, Garcia-Foncillas J, Cruz Hernández JJ, Gascón Vilaplana P, Antón Torres A, Diaz-Rubio E, Feyjoo Saus M, Aranda Aguilar E. López López R, et al. Among authors: aranda aguilar e. Clin Transl Oncol. 2018 May;20(5):613-618. doi: 10.1007/s12094-017-1756-5. Epub 2017 Oct 3. Clin Transl Oncol. 2018. PMID: 28975575
17 results